Associated Papers
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.
Sakuma M et al.
Leukemia, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
VEXAS: A review of current understandings and emerging treatment strategies.
Holden R et al.
Frontiers in Immunology, 2025
VEXAS without vacuoles: Linking genotype to phenotype.
Zhukovsky S et al.
Ejhaem, 2024
VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
Corty RW et al.
Arthritis & Rheumatology (hoboken, N.j.), 2024
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
Sakuma M et al.
Leukemia, 2023
Select a paper to view details